Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-10-09
1988-05-31
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 85, 546 86, A61K 31395, A61K 3140, C07D47104
Patent
active
047481803
ABSTRACT:
New .beta.-carboline-3-carboxylic acid esters have the general formula I: ##STR1## wherein R.sup.4, R.sup.5 and R.sup.6 have specified meanings. The new compounds exhibit surprising psychotropic properties.
REFERENCES:
patent: 3202667 (1984-03-01), Braestrup et al.
patent: 4371536 (1983-02-01), Braestrup et al.
patent: 4435403 (1985-08-01), Szuszkovicz et al.
Jensen et al., Journal of Neural Transmission, 58, 183-191, (1983).
Jensen Leif H.
Petersen Erling N.
Seidelmann Dieter
Watjen Frank
Richter J.
Schering Aktiengesellschaft
Schwartz Richard A.
LandOfFree
.beta.-carboline-3-carboxylic acid derivatives, and their use as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-carboline-3-carboxylic acid derivatives, and their use as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-carboline-3-carboxylic acid derivatives, and their use as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1874528